Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

207 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study introduces a novel transfer learning-based contrastive language-image pretraining adapter (CLIP-adapter) model for predicting the tumor-stroma ratio (TSR) in pancreatic ductal adenocarcinoma (PDAC) using preoperative dual-phase CT images. The primary aim is to develop an efficient and accessible tool for risk stratification and personalized treatment planning.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC

NCT06267690

Pancreatic Cancer

COMPLETED

Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer

NCT04954378

Pancreatic Ductal Adenocarcinoma

COMPLETED

Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data

NCT05313854

Pancreatic Cancer

UNKNOWN

Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy

NCT07243288

Pancreatic Cancer MeSH Term-Pancreatic Cancer, Adult)

ACTIVE_NOT_RECRUITING

A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma

NCT06336694

Pancreatic Neoplasms

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The proposed novel Contrastive Language-Image Pretraining-Adapter (CLIP-adapter) model, leveraging transfer learning, framing CLIP and a self-attention mechanism for predicting TSR in PDAC, in order to exhibit high performance in distinguishing low and high TSR PDAC in the test cohort. We speculated the CLIP-adapter model outperformed single-phase models, specifically CLIP models based on arterial or venous phase images alone. The addition of a feature fusion module could enhance the model's differentiation capacity, emphasizing its superiority over single-phase models. Besides, the model we designed utilized both image and text information during network training, instead of focusing on images only. This underscores the importance of comprehensive assessment in PDAC imaging evaluation, with the potential to contribute to risk stratification and personalized treatment planning.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Ductal Adenocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low TSR and high TSR group

The assessment of the tumor-stroma ratio (TSR) entailed measuring the percentage of tumor and stroma constituents. Based on earlier research, 5/5 was deemed as ideal threshold of TSR measurement.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. patients with pathologically proven PDAC by surgical resection
2. patients who underwent CT scan within a month before surgery
3. observable pancreatic lesions on available images.

Exclusion Criteria

1. any anti-cancer therapy before CT scanning
2. conspicuous interference or significant motion distortions found on images
3. partial clinical data
4. patients with liver metastases or peritoneal carcinomatosis prior to surgical intervention.

Eligible Sex

ALL

Accepts Healthy Volunteers

No